Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Karnataka cabinet...

    Karnataka cabinet approves biotech policy for 2017-22

    Written by Ruby Khatun Khatun Published On 2017-10-02T10:37:22+05:30  |  Updated On 2 Oct 2017 10:37 AM IST
    Karnataka cabinet approves biotech policy for 2017-22

    New Delhi: Karnataka Cabinet gave its approval to the state Biotechnology Policy 2017-22 which will give further impetus for the growth of the sector, state Minister T B Jayachandran said.


    "There is huge potential for Biotechnology in Bengaluru and Karnataka... after similar policy starting in2001 and then again Millennium Biotech Policy, we are now bringing in a new policy for 2017-2022...," he told reporters here.




    The policy "will give further impetus for the sector's growth in the state," the Law and Parliamentary Affairs Minister said.


    He said the policy aims to give support to new innovations in the sector like synthetic biology, anti-microbial resistance, rare diseases, orphan drug, stem cells, regenerative medicines and medical devices.


    The cabinet also approved the establishment of Centre of Excellence for Data Sciences and Artificial Intelligence on a hub and spokes model in Bengaluru at an estimated cost of Rs 40 crores.


    It has also given approval to the implementation of public bicycle sharing system in Bengaluru at an estimated capital cost of Rs 80.18 crore along with approval for the establishment of Special Purpose Vehicle (SPV) for Bengaluru smart city mission, Jayachandra said.


    On the winter session of the Karnataka Legislature, the cabinet authorized the Chief Minister to decide on the schedule, which is most likely to be in November in the northern border state of Belagavi, he said.


    Administrative approval was also given for induction of 3,000 buses to the fleet of Bangalore Metropolitan Transport Corporation out of which 1,500 buses will be purchased and rest will be taken on a lease basis from private, he added.


    Water Resources Minister M B Patil, who was also present at the media briefing, said the cabinet had given nod for the revised estimate of Rs 51,148.94 crore for upper Krishna irrigation project third phase.



    anti-microbial resistanceApprovesBengalurubiotech policyBiotechnology PolicyBiotechnology Policy 2017-22cabinetKarnatakaM B PatilMedical DevicesOrphan Drugstate Ministerstem cellssynthetic biologyT B JayachandranWater Resources Minister
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok